Ngā hua rapu - Dafna D Gladman

Whakamahine hua
  1. 1
    Psoriatic arthritis

    Psoriatic arthritis mā Dafna D. Gladman

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Atherosclerosis in psoriatic disease: latest evidence and clinical implications

    Atherosclerosis in psoriatic disease: latest evidence and clinical implications mā Lihi Eder, Dafna D. Gladman

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program

    Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program mā Dafna D. Gladman, Vimal Chandran

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments

    Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments mā Zahi Touma, Dafna D. Gladman

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Venous syndromes and pulmonary embolism in systemic lupus erythematosus.

    Venous syndromes and pulmonary embolism in systemic lupus erythematosus. mā Dafna D. Gladman, Murray B. Urowitz

    I whakaputaina 1980
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Psoriatic arthritis

    Psoriatic arthritis mā Vanessa Ocampo D, Dafna D. Gladman

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Psoriatic spondyloarthropathy: a long term prospective study.

    Psoriatic spondyloarthropathy: a long term prospective study. mā John G. Hanly, Michelle Russell, Dafna D. Gladman

    I whakaputaina 1988
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies

    Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies mā Konstantinos Tselios, Dafna D. Gladman, Murray B. Urowitz

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Treatment guidelines in psoriatic arthritis

    Treatment guidelines in psoriatic arthritis mā Alexis Ogdie, Laura C. Coates, Dafna D. Gladman

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era

    Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era mā Dafna D. Gladman, Olga Ziouzina, Arane Thavaneswaran, Vinod Chandran

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Predictors for radiological damage in psoriatic arthritis: results from a single centre

    Predictors for radiological damage in psoriatic arthritis: results from a single centre mā Simon Bond, Vernon T. Farewell, Catherine T. Schentag, Dafna D. Gladman

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Excessive paternal transmission in psoriatic arthritis

    Excessive paternal transmission in psoriatic arthritis mā Proton Rahman, Dafna D. Gladman, Catherine T. Schentag, Artūras Petronis

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study

    Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study mā Dafna D. Gladman, John S. Sampalis, OLIVIER ILLOUZ, B. Guérette

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis

    Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis mā V. Chandran, Sita Bhella, Catherine T. Schentag, Dafna D. Gladman

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis

    Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis mā Janice Husted, Arane Thavaneswaran, Vinod Chandran, Dafna D. Gladman

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50

    Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50 mā Zahi Touma, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome

    Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome mā Amanda Steiman, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Psoriatic arthritis assessment tools in clinical trials

    Psoriatic arthritis assessment tools in clinical trials mā Philip J. Mease, Christian Antoni, Dafna D. Gladman, W Taylor

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?

    Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus? mā Zahi Touma, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis

    Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis mā Vinod Chandran, David Tolusso, Richard J. Cook, Dafna D. Gladman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: